Volume 28, Issue 6, November 2013

Maximum dose levels for the rodent comet assay to examine damage at the site of contact or to the gastrointestinal tract

• Abstract
• View article

Can selenium be a modifier of cancer risk in CHEK2 mutation carriers?

• Abstract
• View article

Abnormal mitotic spindle assembly and cytokinesis induced by d-Limonene in cultured mammalian cells

• Abstract
• View article

Evidence for different mechanisms of action behind the mutagenic effects of 4-NOPD and OPD: the role of DNA damage, oxidative stress and an imbalanced nucleotide pool

• Abstract
• View article

CYP1A1 and Cnr nitroreductase bioactivated niclosamide in vitro

• Abstract
• View article

Intracellular deoxyribonucleotide pool imbalance and DNA damage in cells treated with hydroxyurea, an inhibitor of ribonucleotide reductase

• Abstract
• View article

Maternal gene polymorphisms involved in folate metabolism and the risk of having a Down syndrome offspring: a meta-analysis

• Abstract
• View article

Tissue differences in BER-related incision activity and non-specific nuclease activity as measured by the comet assay

• Abstract
• View article

Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies

• Abstract
• View article

Validation of freezing tissues and cells for analysis of DNA strand break levels by comet assay

• Abstract
• View article

Comet assay in reconstructed 3D human epidermal skin models—investigation of intra- and inter-laboratory reproducibility with coded chemicals

• Abstract
• View article

Mechanistic insights into the cytotoxicity and genotoxicity induced by glycidamide in human mammary cells

• Abstract
• View article